New Zealand markets closed

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.1590-0.0019 (-1.18%)
At close: 04:00PM EDT
0.1566 -0.00 (-1.51%)
After hours: 06:07PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.48M
Enterprise value 460.58k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.08
Price/book (mrq)0.37
Enterprise value/revenue 0.04
Enterprise value/EBITDA -0.11

Trading information

Stock price history

Beta (5Y monthly) 1.29
52-week change 3-83.51%
S&P500 52-week change 322.36%
52-week high 31.5200
52-week low 30.1200
50-day moving average 30.1534
200-day moving average 30.4356

Share statistics

Avg vol (3-month) 31.42M
Avg vol (10-day) 3166.32k
Shares outstanding 515.61M
Implied shares outstanding 615.61M
Float 815.35M
% held by insiders 11.56%
% held by institutions 11.95%
Shares short (15 Apr 2024) 4214.16k
Short ratio (15 Apr 2024) 40.26
Short % of float (15 Apr 2024) 41.39%
Short % of shares outstanding (15 Apr 2024) 41.37%
Shares short (prior month 15 Mar 2024) 4117.8k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:9
Last split date 320 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -41.23%
Operating margin (ttm)-26.90%

Management effectiveness

Return on assets (ttm)-19.44%
Return on equity (ttm)-82.87%

Income statement

Revenue (ttm)12.31M
Revenue per share (ttm)1.95
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)N/A
EBITDA -4.27M
Net income avi to common (ttm)-5.08M
Diluted EPS (ttm)-0.8200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.41M
Total cash per share (mrq)0.15
Total debt (mrq)385k
Total debt/equity (mrq)5.75%
Current ratio (mrq)4.07
Book value per share (mrq)0.49

Cash flow statement

Operating cash flow (ttm)-4.99M
Levered free cash flow (ttm)-4.58M